Ryvu Therapeutics SA (RVU) — Cash Flow Reinvestment Rate
Ryvu Therapeutics SA (RVU) has a Cash Flow Reinvestment Rate of 3.31x as of December 2022, reinvesting zł198.08 Million (capex zł4.22 Million plus investments zł-193.87 Million) from operating cash flow of zł59.92 Million. Explore Ryvu Therapeutics SA capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ryvu Therapeutics SA Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Ryvu Therapeutics SA across 2 annual periods. Also explore Ryvu Therapeutics SA balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Ryvu Therapeutics SA (2017–2022)
Year-by-year capital reinvestment analysis for Ryvu Therapeutics SA. For live market cap and broader valuation context, see Ryvu Therapeutics SA stock valuation.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.47x | zł9.98 Million | zł21.32 Million | zł9.29 Million | ▼ -85.8% |
| 2017 | 3.30x | zł36.26 Million | zł10.98 Million | zł21.56 Million | — |